2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia


Creative Commons License

Landmesser U., Chapman M. J., Stock J. K., Amarenco P., Belch J. J. F., Boren J., ...Daha Fazla

EUROPEAN HEART JOURNAL, cilt.39, sa.14, ss.1131-1143, 2018 (SCI-Expanded, Scopus)